Journal of Biological Chemistry · 2001 · 93 citations · 42 references
Life SciencesCell BiologyMolecular BiologyCell SignalingEndocytosisSignal TransductionCell Signaling NetworksGrowth Factor SignalingIntracellular ReceptorsProtein Kinase CascadesReceptor InternalizationEpidermal Growth Factor Receptor EndocytosisEpidermal Growth Factor Receptor SignalingErk SignalingExtracellular Signal-regulated Kinase PathwayPhosphatidylinositol 3-Kinase-akt PathwayPhosphoinositide 3-Kinase-akt ActivationPhosphoinositide 3-Kinase-akt SignalingPi3 Kinase-akt Signaling
N-Acetylglucosaminyltransferase III (GnT-III) is a key enzyme that inhibits the extension ofN-glycans by introducing a bisectingN-acetylglucosamine residue. In this study we investigated the effect of GnT-III on epidermal growth factor (EGF) signaling in HeLaS3 cells. Although the binding of EGF to the epidermal growth factor receptor (EGFR) was decreased in GnT-III transfectants to a level of about 60% of control cells, the EGF-induced activation of extracellular signal-regulated kinase (ERK) in GnT-III transfectants was enhanced to ∼1.4-fold that of the control cells. A binding analysis revealed that only low affinity binding of EGF was decreased in the GnT-III transfectants, whereas high affinity binding, which is considered to be responsible for the downstream signaling, was not altered. EGF-induced autophosphorylation and dimerization of the EGFR in the GnT-III transfectants were the same levels as found in the controls. The internalization rate of EGFR was, however, enhanced in the GnT-III transfectants as judged by the uptake of125I-EGF and Oregon Green-labeled EGF. When the EGFR internalization was delayed by dansylcadaverine, the up-regulation of ERK phosphorylation in GnT-III transfectants was completely suppressed to the same level as control cells. These results suggest that GnT-III overexpression in HeLaS3 cells resulted in an enhancement of EGF-induced ERK phosphorylation at least in part by the up-regulation of the endocytosis of EGFR. N-Acetylglucosaminyltransferase III (GnT-III) is a key enzyme that inhibits the extension ofN-glycans by introducing a bisectingN-acetylglucosamine residue. In this study we investigated the effect of GnT-III on epidermal growth factor (EGF) signaling in HeLaS3 cells. Although the binding of EGF to the epidermal growth factor receptor (EGFR) was decreased in GnT-III transfectants to a level of about 60% of control cells, the EGF-induced activation of extracellular signal-regulated kinase (ERK) in GnT-III transfectants was enhanced to ∼1.4-fold that of the control cells. A binding analysis revealed that only low affinity binding of EGF was decreased in the GnT-III transfectants, whereas high affinity binding, which is considered to be responsible for the downstream signaling, was not altered. EGF-induced autophosphorylation and dimerization of the EGFR in the GnT-III transfectants were the same levels as found in the controls. The internalization rate of EGFR was, however, enhanced in the GnT-III transfectants as judged by the uptake of125I-EGF and Oregon Green-labeled EGF. When the EGFR internalization was delayed by dansylcadaverine, the up-regulation of ERK phosphorylation in GnT-III transfectants was completely suppressed to the same level as control cells. These results suggest that GnT-III overexpression in HeLaS3 cells resulted in an enhancement of EGF-induced ERK phosphorylation at least in part by the up-regulation of the endocytosis of EGFR. It is a generally accepted fact that N-glycans play an important role in the folding, stability, and sorting of glycoproteins (1Dwek R.A. Science. 1995; 269: 1234-1235Crossref PubMed Scopus (107) Google Scholar, 2Wyss D.F. Choi J.S. Li J. Knoppers M.H. Willis K.J. Arulanandam A.R.N. Smolyar A. Reinherz E.L. Wagner G. Science. 1995; 269: 1273-1278Crossref PubMed Scopus (302) Google Scholar). They have a common core structure, and their branching patterns are determined by glycosyltransferases (3Schachter H. Biochem. Cell Biol. 1986; 64: 163-181Crossref PubMed Scopus (489) Google Scholar, 4Taniguchi N. Ihara Y. Glycoconjugate J. 1995; 12: 733-738Crossref PubMed Scopus (31) Google Scholar, 5Taniguchi N. Miyoshi E. Ko J.H. Ikeda Y. Ihara Y. Biochim. Biophys. Acta. 1999; 1455: 287-300Crossref PubMed Scopus (137) Google Scholar, 6Dennis J.W. Granovsky M. Warren C.E. Biochim. Biophys. Acta. 1999; 1473: 21-34Crossref PubMed Scopus (601) Google Scholar). β1–4N-Acetylglucosaminyltransferase III (GnT-III)1 catalyzes the addition of N-acetylglucosamine (GlcNAc) to the β-mannoside of the tri-mannose core, to produce a bisecting GlcNAc (7Narasimhan S. J. Biol. Chem. 1982; 257: 10235-10242Abstract Full Text PDF PubMed Google Scholar, 8Nishikawa A. Ihara Y. Hatakeyama M. Kangawa K. Taniguchi N. J. Biol. Chem. 1992; 267: 18199-18220.4Abstract Full Text PDF PubMed Google Scholar). The introduction of a bisecting GlcNAc results in the suppression of further processing and elongation ofN-glycans, since other glycosyltransferases are not able to act on the resulting bianntennary sugar chains. To elucidate the biological function of bisecting GlcNAc, GnT-III-overexpressing transfectants have been examined from many aspects (9Yoshimura M. Nishikawa A. Ihara Y. Taniguchi S. Taniguchi N. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 8754-8758Crossref PubMed Scopus (254) Google Scholar, 10Yoshimura M. Ihara Y. Matsuzawa Y. Taniguchi N. J. Biol. Chem. 1996; 271: 13811-13815Abstract Full Text Full Text PDF PubMed Scopus (177) Google Scholar, 11Sheng Y. Yoshimura M. Inoue S. Oritani K. Nishiura T. Yoshida H. Ogawa M. Okajima Y. Matsuzawa Y. Taniguchi N. Int. J. Cancer. 1997; 73: 850-858Crossref PubMed Scopus (31) Google Scholar, 12Yoshimura M. Ihara Y. Ohnishi A. Ijuhin N. Nishiura T. Kanakura Y. Matsuzawa Y. Taniguchi N. Cancer Res. 1996; 56: 412-418PubMed Google Scholar, 13Miyoshi E. Ihara Y. Hayashi N. Fusamoto H. Kamada T. Taniguchi N. J. Biol. Chem. 1995; 270: 28311-28315Abstract Full Text Full Text PDF PubMed Scopus (43) Google Scholar, 14Ihara Y. Sakamoto Y. Mihara M. Shimizu K. Taniguchi N. J. Biol. Chem. 1997; 272: 9629-9634Abstract Full Text Full Text PDF PubMed Scopus (72) Google Scholar, 15Rebbaa A. Yamamoto H. Saito T. Meuillet E. Kim P. Kersey D.S. Bremer E.G. Taniguchi N. Moskal J.R. J. Biol. Chem. 1997; 272: 9275-9279Abstract Full Text Full Text PDF PubMed Scopus (84) Google Scholar). For example, we previously reported that the introduction of GnT-III in B16 mouse melanoma cells suppresses lung metastasis (9Yoshimura M. Nishikawa A. Ihara Y. Taniguchi S. Taniguchi N. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 8754-8758Crossref PubMed Scopus (254) Google Scholar), increases E-cadherin-mediated homotypic adhesion (10Yoshimura M. Ihara Y. Matsuzawa Y. Taniguchi N. J. Biol. Chem. 1996; 271: 13811-13815Abstract Full Text Full Text PDF PubMed Scopus (177) Google Scholar), and enhances cell adhesion to hyaluronate via the modulation of N-glycans of CD44 (11Sheng Y. Yoshimura M. Inoue S. Oritani K. Nishiura T. Yoshida H. Ogawa M. Okajima Y. Matsuzawa Y. Taniguchi N. Int. J. Cancer. 1997; 73: 850-858Crossref PubMed Scopus (31) Google Scholar). GnT-III transfection also reduces the susceptibility of human leukemia K562 cells to the cytotoxicity of natural killer cells (12Yoshimura M. Ihara Y. Ohnishi A. Ijuhin N. Nishiura T. Kanakura Y. Matsuzawa Y. Taniguchi N. Cancer Res. 1996; 56: 412-418PubMed Google Scholar) and suppresses the expression of hepatitis B virus in a hepatoma cell line (13Miyoshi E. Ihara Y. Hayashi N. Fusamoto H. Kamada T. Taniguchi N. J. Biol. Chem. 1995; 270: 28311-28315Abstract Full Text Full Text PDF PubMed Scopus (43) Google Scholar). It has been reported that GnT-III overexpression affects signal transduction such as nerve growth factor signaling by suppressing the dimerization of Trk A on PC12 cells (14Ihara Y. Sakamoto Y. Mihara M. Shimizu K. Taniguchi N. J. Biol. Chem. 1997; 272: 9629-9634Abstract Full Text Full Text PDF PubMed Scopus (72) Google Scholar).Epidermal growth factor receptor (EGFR) is one of membrane glycoproteins and the oligosaccharide side chains linked to the extracellular domain are essential for its function (16Soderquist A.M. Carpenter G. J. Biol. Chem. 1984; 259: 12586-12594Abstract Full Text PDF PubMed Google Scholar, 17Gamou S. Shimizu N. J. Biochem. 1988; 104: 388-396Crossref PubMed Scopus (37) Google Scholar, 18Tsuda T. Ikeda Y. Taniguchi N. J. Biol. Chem. 2000; 275: 21988-21994Abstract Full Text Full Text PDF PubMed Scopus (96) Google Scholar). However, the relevance of the composition and structure of N-glycans to epidermal growth factor (EGF) signaling is not fully understood. It was previously reported that the EGF binding to its receptor is significantly decreased in GnT-III-transfected human glioma cells U373 MG (15Rebbaa A. Yamamoto H. Saito T. Meuillet E. Kim P. Kersey D.S. Bremer E.G. Taniguchi N. Moskal J.R. J. Biol. Chem. 1997; 272: 9275-9279Abstract Full Text Full Text PDF PubMed Scopus (84) Google Scholar). In this paper, we report on a study involving the downstream EGF signaling in GnT-III-transfected HeLaS3 cells to further elucidate the mechanism by which this enzyme affects EGF signaling. Our findings show that the internalization rate of EGFR was up-regulated and that EGF-induced extracellular signal-regulated kinase (ERK) phosphorylation was enhanced in the GnT-III transfectants.DISCUSSIONIn this paper, we report on a study of the effect of GnT-III transfection on EGF signaling in HeLaS3 cells. Consistent with our previous report (15Rebbaa A. Yamamoto H. Saito T. Meuillet E. Kim P. Kersey D.S. Bremer E.G. Taniguchi N. Moskal J.R. J. Biol. Chem. 1997; 272: 9275-9279Abstract Full Text Full Text PDF PubMed Scopus (84) Google Scholar), EGF binding to its receptor was significantly decreased in GnT-III transfectants. However, our findings showed that EGF-induced ERK phosphorylation was up-regulated in the GnT-III transfectants. To know the mechanism by which ERK phosphorylation is up-regulated, we first examined EGF binding to EGFR in GnT-III transfectants. A Scatchard analysis of the binding assay data revealed that only low affinity binding was decreased in the GnT-III transfectants, whereas the high affinity binding was not changed. The fact that the cell surface expression of EGFR was not altered in GnT-III transfectants suggests that about 40% of the low affinity their whereas high affinity EGFR dimerization and autophosphorylation were not in the GnT-III transfectants, which is with the fact that the high affinity which of the EGFR is and for EGF-induced J. J. T. J. Cell Biol. PubMed Scopus Google Scholar, A. J. S. J. Cell Biol. PubMed Scopus Google high affinity and low affinity EGFR has not been fully It has been that the part of the EGFR its affinity for EGF. It was that the activation of high affinity EGFR to low affinity EGFR P. J. Biol. Chem. 1982; 257: Full Text PDF PubMed Google Scholar), a of the domain E. N. Y. A. J. J. Biol. Chem. 1986; Full Text PDF PubMed Google Scholar) domain from to M. J. 1997; PubMed Scopus Google Scholar) the high affinity and cells that a the for high affinity binding of EGFR T. E. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). It has been also that high affinity EGFR the J. Cell Biol. PubMed Scopus Google Scholar, J. J. Cell Biol. 1986; PubMed Scopus Google Scholar, J. PubMed Scopus Google Scholar, P. J. Cell Res. 1992; PubMed Scopus Google Scholar). mechanism by which GnT-III overexpression the EGF binding of low affinity receptor is that GnT-III transfection the of the domain of EGFR. that GnT-III overexpression in cells the of EGFR the which a part of domain of EGFR Y. and N. the introduction of GnT-III in of the domain of EGFR. mechanism is that GnT-III affects an the of which has been by M. J. 1997; PubMed Scopus Google this we that the overexpression of GnT-III the internalization rate of EGFR. effect to since internalization rate of receptor was not which is by A. T. A. J. 1999; PubMed Scopus Google Scholar). The internalization of the EGFR is generally to be essential for ERK activation Cell Biol. 1999; PubMed Scopus Google Scholar, Cell Biol. 2000; 12: PubMed Scopus Google Scholar), as as the internalization of other such as receptor Biol. PubMed Scopus Google Scholar), growth factor receptor G. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar), receptor Y. S. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar), and receptor Y. J.R. J. Biol. Chem. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar). have also that signaling in with EGFR in to EGF and a role for membrane in EGF signaling J. PubMed Scopus Google Scholar, T. A. A. J. Cell Sci. 1999; PubMed Google Scholar, E. N. J. 2000; PubMed Scopus Google Scholar). the up-regulation of the internalization rate of EGFR in GnT-III transfectants be in the enhancement of downstream signaling. A. J. Biol. Chem. 2000; 275: Full Text Full Text PDF PubMed Scopus (72) Google Scholar) that endocytosis of EGFR affects downstream of that activation levels of were not in GnT-III transfectants with transfectants not also the that the enhancement of ERK activation in GnT-III transfectants is to the of internalization of by which GnT-III overexpression affects endocytosis is Y. G. Biol. 2000; PubMed Scopus Google Scholar) reported that the internalization of is by and that which is in cells, in They that of the a of and that this enhances the of endocytosis such as Our results are with this since GnT-III overexpression suppresses the processing and elongation of of enhancement of endocytosis is the in the domain of EGFR as The are in the the EGF-induced and internalization Full Text PDF PubMed Scopus Google Scholar), and the domain a of the of the such as which in the receptor internalization was reported that the of is in M. T. S. J. P. Cancer Res. Google Scholar, M. S. C.E. P. Cancer Res. 2000; Google Scholar). They that GnT-III an important role in in that ERK phosphorylation is up-regulated in GnT-III transfectants, and for the of are with a of and the that are in of EGF signaling in GnT-III transfectants. It is a generally accepted fact that N-glycans play an important role in the folding, stability, and sorting of glycoproteins (1Dwek R.A. Science. 1995; 269: 1234-1235Crossref PubMed Scopus (107) Google Scholar, 2Wyss D.F. Choi J.S. Li J. Knoppers M.H. Willis K.J. Arulanandam A.R.N. Smolyar A. Reinherz E.L. Wagner G. Science. 1995; 269: 1273-1278Crossref PubMed Scopus (302) Google Scholar). They have a common core structure, and their branching patterns are determined by glycosyltransferases (3Schachter H. Biochem. Cell Biol. 1986; 64: 163-181Crossref PubMed Scopus (489) Google Scholar, 4Taniguchi N. Ihara Y. Glycoconjugate J. 1995; 12: 733-738Crossref PubMed Scopus (31) Google Scholar, 5Taniguchi N. Miyoshi E. Ko J.H. Ikeda Y. Ihara Y. Biochim. Biophys. Acta. 1999; 1455: 287-300Crossref PubMed Scopus (137) Google Scholar, 6Dennis J.W. Granovsky M. Warren C.E. Biochim. Biophys. Acta. 1999; 1473: 21-34Crossref PubMed Scopus (601) Google Scholar). β1–4N-Acetylglucosaminyltransferase III (GnT-III)1 catalyzes the addition of N-acetylglucosamine (GlcNAc) to the β-mannoside of the tri-mannose core, to produce a bisecting GlcNAc (7Narasimhan S. J. Biol. Chem. 1982; 257: 10235-10242Abstract Full Text PDF PubMed Google Scholar, 8Nishikawa A. Ihara Y. Hatakeyama M. Kangawa K. Taniguchi N. J. Biol. Chem. 1992; 267: 18199-18220.4Abstract Full Text PDF PubMed Google Scholar). The introduction of a bisecting GlcNAc results in the suppression of further processing and elongation ofN-glycans, since other glycosyltransferases are not able to act on the resulting bianntennary sugar chains. To elucidate the biological function of bisecting GlcNAc, GnT-III-overexpressing transfectants have been examined from many aspects (9Yoshimura M. Nishikawa A. Ihara Y. Taniguchi S. Taniguchi N. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 8754-8758Crossref PubMed Scopus (254) Google Scholar, 10Yoshimura M. Ihara Y. Matsuzawa Y. Taniguchi N. J. Biol. Chem. 1996; 271: 13811-13815Abstract Full Text Full Text PDF PubMed Scopus (177) Google Scholar, 11Sheng Y. Yoshimura M. Inoue S. Oritani K. Nishiura T. Yoshida H. Ogawa M. Okajima Y. Matsuzawa Y. Taniguchi N. Int. J. Cancer. 1997; 73: 850-858Crossref PubMed Scopus (31) Google Scholar, 12Yoshimura M. Ihara Y. Ohnishi A. Ijuhin N. Nishiura T. Kanakura Y. Matsuzawa Y. Taniguchi N. Cancer Res. 1996; 56: 412-418PubMed Google Scholar, 13Miyoshi E. Ihara Y. Hayashi N. Fusamoto H. Kamada T. Taniguchi N. J. Biol. Chem. 1995; 270: 28311-28315Abstract Full Text Full Text PDF PubMed Scopus (43) Google Scholar, 14Ihara Y. Sakamoto Y. Mihara M. Shimizu K. Taniguchi N. J. Biol. Chem. 1997; 272: 9629-9634Abstract Full Text Full Text PDF PubMed Scopus (72) Google Scholar, 15Rebbaa A. Yamamoto H. Saito T. Meuillet E. Kim P. Kersey D.S. Bremer E.G. Taniguchi N. Moskal J.R. J. Biol. Chem. 1997; 272: 9275-9279Abstract Full Text Full Text PDF PubMed Scopus (84) Google Scholar). For example, we previously reported that the introduction of GnT-III in B16 mouse melanoma cells suppresses lung metastasis (9Yoshimura M. Nishikawa A. Ihara Y. Taniguchi S. Taniguchi N. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 8754-8758Crossref PubMed Scopus (254) Google Scholar), increases E-cadherin-mediated homotypic adhesion (10Yoshimura M. Ihara Y. Matsuzawa Y. Taniguchi N. J. Biol. Chem. 1996; 271: 13811-13815Abstract Full Text Full Text PDF PubMed Scopus (177) Google Scholar), and enhances cell adhesion to hyaluronate via the modulation of N-glycans of CD44 (11Sheng Y. Yoshimura M. Inoue S. Oritani K. Nishiura T. Yoshida H. Ogawa M. Okajima Y. Matsuzawa Y. Taniguchi N. Int. J. Cancer. 1997; 73: 850-858Crossref PubMed Scopus (31) Google Scholar). GnT-III transfection also reduces the susceptibility of human leukemia K562 cells to the cytotoxicity of natural killer cells (12Yoshimura M. Ihara Y. Ohnishi A. Ijuhin N. Nishiura T. Kanakura Y. Matsuzawa Y. Taniguchi N. Cancer Res. 1996; 56: 412-418PubMed Google Scholar) and suppresses the expression of hepatitis B virus in a hepatoma cell line (13Miyoshi E. Ihara Y. Hayashi N. Fusamoto H. Kamada T. Taniguchi N. J. Biol. Chem. 1995; 270: 28311-28315Abstract Full Text Full Text PDF PubMed Scopus (43) Google Scholar). It has been reported that GnT-III overexpression affects signal transduction such as nerve growth factor signaling by suppressing the dimerization of Trk A on PC12 cells (14Ihara Y. Sakamoto Y. Mihara M. Shimizu K. Taniguchi N. J. Biol. Chem. 1997; 272: 9629-9634Abstract Full Text Full Text PDF PubMed Scopus (72) Google Scholar). growth factor receptor (EGFR) is one of membrane glycoproteins and the oligosaccharide side chains linked to the extracellular domain are essential for its function (16Soderquist A.M. Carpenter G. J. Biol. Chem. 1984; 259: 12586-12594Abstract Full Text PDF PubMed Google Scholar, 17Gamou S. Shimizu N. J. Biochem. 1988; 104: 388-396Crossref PubMed Scopus (37) Google Scholar, 18Tsuda T. Ikeda Y. Taniguchi N. J. Biol. Chem. 2000; 275: 21988-21994Abstract Full Text Full Text PDF PubMed Scopus (96) Google Scholar). However, the relevance of the composition and structure of N-glycans to epidermal growth factor (EGF) signaling is not fully understood. It was previously reported that the EGF binding to its receptor is significantly decreased in GnT-III-transfected human glioma cells U373 MG (15Rebbaa A. Yamamoto H. Saito T. Meuillet E. Kim P. Kersey D.S. Bremer E.G. Taniguchi N. Moskal J.R. J. Biol. Chem. 1997; 272: 9275-9279Abstract Full Text Full Text PDF PubMed Scopus (84) Google Scholar). In this paper, we report on a study involving the downstream EGF signaling in GnT-III-transfected HeLaS3 cells to further elucidate the mechanism by which this enzyme affects EGF signaling. Our findings show that the internalization rate of EGFR was up-regulated and that EGF-induced extracellular signal-regulated kinase (ERK) phosphorylation was enhanced in the GnT-III transfectants. this paper, we report on a study of the effect of GnT-III transfection on EGF signaling in HeLaS3 cells. Consistent with our previous report (15Rebbaa A. Yamamoto H. Saito T. Meuillet E. Kim P. Kersey D.S. Bremer E.G. Taniguchi N. Moskal J.R. J. Biol. Chem. 1997; 272: 9275-9279Abstract Full Text Full Text PDF PubMed Scopus (84) Google Scholar), EGF binding to its receptor was significantly decreased in GnT-III transfectants. However, our findings showed that EGF-induced ERK phosphorylation was up-regulated in the GnT-III transfectants. To know the mechanism by which ERK phosphorylation is up-regulated, we first examined EGF binding to EGFR in GnT-III transfectants. A Scatchard analysis of the binding assay data revealed that only low affinity binding was decreased in the GnT-III transfectants, whereas the high affinity binding was not changed. The fact that the cell surface expression of EGFR was not altered in GnT-III transfectants suggests that about 40% of the low affinity their whereas high affinity EGFR dimerization and autophosphorylation were not in the GnT-III transfectants, which is with the fact that the high affinity which of the EGFR is and for EGF-induced J. J. T. J. Cell Biol. PubMed Scopus Google Scholar, A. J. S. J. Cell Biol. PubMed Scopus Google high affinity and low affinity EGFR has not been fully It has been that the part of the EGFR its affinity for EGF. It was that the activation of high affinity EGFR to low affinity EGFR P. J. Biol. Chem. 1982; 257: Full Text PDF PubMed Google Scholar), a of the domain E. N. Y. A. J. J. Biol. Chem. 1986; Full Text PDF PubMed Google Scholar) domain from to M. J. 1997; PubMed Scopus Google Scholar) the high affinity and cells that a the for high affinity binding of EGFR T. E. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). It has been also that high affinity EGFR the J. Cell Biol. PubMed Scopus Google Scholar, J. J. Cell Biol. 1986; PubMed Scopus Google Scholar, J. PubMed Scopus Google Scholar, P. J. Cell Res. 1992; PubMed Scopus Google Scholar). mechanism by which GnT-III overexpression the EGF binding of low affinity receptor is that GnT-III transfection the of the domain of EGFR. that GnT-III overexpression in cells the of EGFR the which a part of domain of EGFR Y. and N. the introduction of GnT-III in of the domain of EGFR. mechanism is that GnT-III affects an the of which has been by M. J. 1997; PubMed Scopus Google this we that the overexpression of GnT-III the internalization rate of EGFR. effect to since internalization rate of receptor was not which is by A. T. A. J. 1999; PubMed Scopus Google Scholar). The internalization of the EGFR is generally to be essential for ERK activation Cell Biol. 1999; PubMed Scopus Google Scholar, Cell Biol. 2000; 12: PubMed Scopus Google Scholar), as as the internalization of other such as receptor Biol. PubMed Scopus Google Scholar), growth factor receptor G. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar), receptor Y. S. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar), and receptor Y. J.R. J. Biol. Chem. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar). have also that signaling in with EGFR in to EGF and a role for membrane in EGF signaling J. PubMed Scopus Google Scholar, T. A. A. J. Cell Sci. 1999; PubMed Google Scholar, E. N. J. 2000; PubMed Scopus Google Scholar). the up-regulation of the internalization rate of EGFR in GnT-III transfectants be in the enhancement of downstream signaling. A. J. Biol. Chem. 2000; 275: Full Text Full Text PDF PubMed Scopus (72) Google Scholar) that endocytosis of EGFR affects downstream of that activation levels of were not in GnT-III transfectants with transfectants not also the that the enhancement of ERK activation in GnT-III transfectants is to the of internalization of by which GnT-III overexpression affects endocytosis is Y. G. Biol. 2000; PubMed Scopus Google Scholar) reported that the internalization of is by and that which is in cells, in They that of the a of and that this enhances the of endocytosis such as Our results are with this since GnT-III overexpression suppresses the processing and elongation of of enhancement of endocytosis is the in the domain of EGFR as The are in the the EGF-induced and internalization Full Text PDF PubMed Scopus Google Scholar), and the domain a of the of the such as which in the receptor internalization was reported that the of is in M. T. S. J. P. Cancer Res. Google Scholar, M. S. C.E. P. Cancer Res. 2000; Google Scholar). They that GnT-III an important role in in that ERK phosphorylation is up-regulated in GnT-III transfectants, and for the of are with a of and the that are in of EGF signaling in GnT-III transfectants. In this paper, we report on a study of the effect of GnT-III transfection on EGF signaling in HeLaS3 cells. Consistent with our previous report (15Rebbaa A. Yamamoto H. Saito T. Meuillet E. Kim P. Kersey D.S. Bremer E.G. Taniguchi N. Moskal J.R. J. Biol. Chem. 1997; 272: 9275-9279Abstract Full Text Full Text PDF PubMed Scopus (84) Google Scholar), EGF binding to its receptor was significantly decreased in GnT-III transfectants. However, our findings showed that EGF-induced ERK phosphorylation was up-regulated in the GnT-III transfectants. To know the mechanism by which ERK phosphorylation is up-regulated, we first examined EGF binding to EGFR in GnT-III transfectants. A Scatchard analysis of the binding assay data revealed that only low affinity binding was decreased in the GnT-III transfectants, whereas the high affinity binding was not changed. The fact that the cell surface expression of EGFR was not altered in GnT-III transfectants suggests that about 40% of the low affinity their whereas high affinity EGFR dimerization and autophosphorylation were not in the GnT-III transfectants, which is with the fact that the high affinity which of the EGFR is and for EGF-induced J. J. T. J. Cell Biol. PubMed Scopus Google Scholar, A. J. S. J. Cell Biol. PubMed Scopus Google Scholar). The high affinity and low affinity EGFR has not been fully It has been that the part of the EGFR its affinity for EGF. It was that the activation of high affinity EGFR to low affinity EGFR P. J. Biol. Chem. 1982; 257: Full Text PDF PubMed Google Scholar), a of the domain E. N. Y. A. J. J. Biol. Chem. 1986; Full Text PDF PubMed Google Scholar) domain from to M. J. 1997; PubMed Scopus Google Scholar) the high affinity and cells that a the for high affinity binding of EGFR T. E. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). It has been also that high affinity EGFR the J. Cell Biol. PubMed Scopus Google Scholar, J. J. Cell Biol. 1986; PubMed Scopus Google Scholar, J. PubMed Scopus Google Scholar, P. J. Cell Res. 1992; PubMed Scopus Google Scholar). mechanism by which GnT-III overexpression the EGF binding of low affinity receptor is that GnT-III transfection the of the domain of EGFR. that GnT-III overexpression in cells the of EGFR the which a part of domain of EGFR Y. and N. the introduction of GnT-III in of the domain of EGFR. mechanism is that GnT-III affects an the of which has been by M. J. 1997; PubMed Scopus Google Scholar). In this we that the overexpression of GnT-III the internalization rate of EGFR. effect to since internalization rate of receptor was not which is by A. T. A. J. 1999; PubMed Scopus Google Scholar). The internalization of the EGFR is generally to be essential for ERK activation Cell Biol. 1999; PubMed Scopus Google Scholar, Cell Biol. 2000; 12: PubMed Scopus Google Scholar), as as the internalization of other such as receptor Biol. PubMed Scopus Google Scholar), growth factor receptor G. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar), receptor Y. S. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar), and receptor Y. J.R. J. Biol. Chem. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar). have also that signaling in with EGFR in to EGF and a role for membrane in EGF signaling J. PubMed Scopus Google Scholar, T. A. A. J. Cell Sci. 1999; PubMed Google Scholar, E. N. J. 2000; PubMed Scopus Google Scholar). the up-regulation of the internalization rate of EGFR in GnT-III transfectants be in the enhancement of downstream signaling. A. J. Biol. Chem. 2000; 275: Full Text Full Text PDF PubMed Scopus (72) Google Scholar) that endocytosis of EGFR affects downstream of that activation levels of were not in GnT-III transfectants with transfectants not also the that the enhancement of ERK activation in GnT-III transfectants is to the of internalization of EGFR. The by which GnT-III overexpression affects endocytosis is Y. G. Biol. 2000; PubMed Scopus Google Scholar) reported that the internalization of is by and that which is in cells, in They that of the a of and that this enhances the of endocytosis such as Our results are with this since GnT-III overexpression suppresses the processing and elongation of of enhancement of endocytosis is the in the domain of EGFR as The are in the the EGF-induced and internalization Full Text PDF PubMed Scopus Google Scholar), and the domain a of the of the such as which in the receptor internalization It was reported that the of is in M. T. S. J. P. Cancer Res. Google Scholar, M. S. C.E. P. Cancer Res. 2000; Google Scholar). They that GnT-III an important role in in that ERK phosphorylation is up-regulated in GnT-III transfectants, and for the of are with a of and the that are in of EGF signaling in GnT-III transfectants. Ihara for epidermal growth factor epidermal growth factor receptor extracellular signal-regulated kinase with
42